Hypothesis and Theory
Published on 06 Aug 2024
Integrating electromagnetic cancer stress with immunotherapy: a therapeutic paradigm
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1417621
Type at least 3 characters
1,708 articles
Articles
Original Research
Accepted on 05 Aug 2024
Conserved allomorphs of MR1 drive specificity of MR1-restricted TCRs
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1419528
Review
Accepted on 05 Aug 2024
Targeted Radionuclide Therapy for Head and Neck Squamous Cell Carcinoma: A Review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1445191
Original Research
Accepted on 05 Aug 2024
Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1448890
Mini Review
Published on 05 Aug 2024
Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1456631
- 210 views
Review
Published on 02 Aug 2024
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1441222
- 158 views
Case Report
Accepted on 01 Aug 2024
Case Report: A rare case of malignant solitary fibrous tumor in an adult with an epithelioid pattern in the occipital region
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1339582
Review
Accepted on 01 Aug 2024
Radiotherapy and breast cancer; finally, an lncRNA perspective on radiosensitivity and radioresistance
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1437542
Review
Published on 01 Aug 2024
The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1445025
- 161 views
Case Report
Published on 25 Jul 2024
Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1399021
- 237 views
Original Research
Published on 25 Jul 2024
Trabectedin may be a valuable treatment option for elderly patients with metastatic soft tissue sarcomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1437732
- 229 views
Review
Accepted on 24 Jul 2024
The mechanism of ITGB4 in tumor migration and invasion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1421902
Review
Accepted on 23 Jul 2024
Biological Functions and Therapeutic Potential of CKS2 in human cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1424569
Original Research
Accepted on 23 Jul 2024
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1447807
Case Report
Accepted on 19 Jul 2024
Case report: A case of Savolitinib in the treatment of MET amplification mutation advanced lung adenocarcinoma with rare bilateral breast metastasis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1450855
Review
Published on 18 Jul 2024
Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1388484
- 367 views